NDRA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 13:00):

Stats
Today's Volume	35 729.00
Average Volume	176 320
Market Cap	2.98M
EPS	$-0.0500 ( 2024-03-28 )
Next earnings date	( $-0.370 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.170
ATR14	$0.00800 (2.96%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Basenese Lou	Buy	600	Stock Options
2024-01-02	Harsh Michael	Buy	600	Stock Options
2024-01-02	Digiandomenico Anthony	Buy	600	Stock Options
2024-01-02	Tokman Alexander Y	Buy	600	Stock Options
2023-05-18	Thornton Michael Milos	Buy	15 000	Common Stock

INSIDER POWER
100.00
Last 100 transactions
Buy: 3 706 167 \| Sell: 432 712

Volume Correlation

Long: 0.21 (neutral)

Short: 0.41 (neutral)

Signal:(41.385) Neutral

ENDRA Life Sciences Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ENDRA Life Sciences Inc Correlation - Currency/Commodity

0.46
( neutral )

0.50
( weak )

0.00
( neutral )

-0.78
( moderate negative )

-0.52
( weak negative )

ENDRA Life Sciences Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-275 451 (0.00 %)
EPS:	$-1.580

FY	2023
Revenue:	$0
Gross Profit:	$-275 451 (0.00 %)
EPS:	$-1.580

FY	2022
Revenue:	$0
Gross Profit:	$-234 258 (0.00 %)
EPS:	$-4.57

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-11.83

Financial Reports:

No articles found.

ENDRA Life Sciences Inc

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.